Previous studies have explored the effects of various PDE-4 inhibitors on cutaneous sarcoidosis [21], their steroid-sparing potential [22], and their role in stabilizing fibrotic sarcoidosis [18]. The gene discussed is PDE4A; the disease is skin sarcoidosis.